mTOR activation triggers proinflammatory expansion of IL-4-producing and necrosis-prone double-negative T cells, precedes flares, and serves as target for treatment in patients with systemic lupus erythematosus

Gelijkaardige items

• MTOR ACTIVATION TRIGGERS IL-4 PRODUCTION AND NECROTIC DEATH OF DOUBLE-NEGATIVE T CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYHTHEMATOSUS
  door: Lai, Zhi-Wei, et al.
  Gepubliceerd in: (2013)
• mTOR-dependent autophagy contributes to end-organ resistance and serves as target for treatment in autoimmune disease
  door: Perl, Andras
  Gepubliceerd in: (2018)
• N-ACETYLCYSTEINE REDUCES DISEASE ACTIVITY BY BLOCKING MTOR IN T CELLS OF LUPUS PATIENTS
  door: Lai, Zhi-Wei, et al.
  Gepubliceerd in: (2012)
• Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
  door: Lai, Zhi-Wei, et al.
  Gepubliceerd in: (2018)
• Lymphoedema: a paradoxical effect of tumour necrosis factor inhibitors – case report and review of literature
  door: Tily, Hajra Ismail, et al.
  Gepubliceerd in: (2009)